{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T03:41:47Z","timestamp":1777002107537,"version":"3.51.4"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Sciences Foundation of China","doi-asserted-by":"crossref","award":["81530097"],"award-info":[{"award-number":["81530097"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Sciences Foundation of China","doi-asserted-by":"crossref","award":["81222051"],"award-info":[{"award-number":["81222051"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"National Key Technology R&D Program \u201cNew Drug Innovation\u201d of China","award":["2018ZX09711001-008-003"],"award-info":[{"award-number":["2018ZX09711001-008-003"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"published-print":{"date-parts":[[2019,1]]},"DOI":"10.1016\/j.jpba.2018.09.049","type":"journal-article","created":{"date-parts":[[2018,9,28]],"date-time":"2018-09-28T23:36:49Z","timestamp":1538177809000},"page":"64-77","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"special_numbering":"C","title":["1H NMR-based dynamic metabolomics delineates the therapeutic effects of Baoyuan decoction on isoproterenol-induced cardiac hypertrophy"],"prefix":"10.1016","volume":"163","author":[{"given":"Zhiyong","family":"Du","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ran","family":"Wen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qian","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jinlong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yingyuan","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mingbo","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoyu","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pengfei","family":"Tu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yong","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpba.2018.09.049_bib0005","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1016\/j.ijcard.2012.09.082","article-title":"Mitochondrial function in cardiac hypertrophy","volume":"167","author":"Zhou","year":"2013","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.jpba.2018.09.049_bib0010","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.yjmcc.2017.06.007","article-title":"Cardiomyocyte specific overexpression of a 37 amino acid domain of regulator of G protein signalling 2 inhibits cardiac hypertrophy and improves function in response to pressure overload in mice","volume":"108","author":"Lee","year":"2017","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.jpba.2018.09.049_bib0015","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.intimp.2017.05.002","article-title":"Stachydrine ameliorates isoproterenol-induced cardiac hypertrophy and fibrosis by suppressing inflammation and oxidative stress through inhibiting NF-\u03baB and JAK\/STAT signaling pathways in rats","volume":"48","author":"Zhao","year":"2017","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.jpba.2018.09.049_bib0020","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.bcp.2013.11.015","article-title":"Alterations in cytochrome P450-derived arachidonic acid metabolism during pressure overload-induced cardiac hypertrophy","volume":"87","author":"El-Sherbeni","year":"2014","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.jpba.2018.09.049_bib0025","doi-asserted-by":"crossref","first-page":"141","DOI":"10.4149\/gpb_2012_015","article-title":"Morphological and functional characteristics of models of experimental myocardial injury induced by isoproterenol","volume":"31","author":"Nichtova","year":"2012","journal-title":"Gen. Physiol. Biophys."},{"key":"10.1016\/j.jpba.2018.09.049_bib0030","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.cels.2016.10.016","article-title":"Systems genetics approach identifies gene pathways and adamts2 as drivers of isoproterenol-induced cardiac hypertrophy and cardiomyopathy in mice","volume":"4","author":"Rau","year":"2017","journal-title":"Cell Syst."},{"key":"10.1016\/j.jpba.2018.09.049_bib0035","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.pharmthera.2017.10.013","article-title":"Hormesis as a mechanistic approach to understanding herbal treatments in traditional Chinese medicine","volume":"184","author":"Wang","year":"2018","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.jpba.2018.09.049_bib0040","doi-asserted-by":"crossref","first-page":"38379","DOI":"10.1038\/srep38379","article-title":"An integrated strategy for global qualitative and quantitative profiling of traditional Chinese medicine formulas: baoyuan decoction as a case","volume":"6","author":"Ma","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jpba.2018.09.049_bib0045","doi-asserted-by":"crossref","first-page":"505","DOI":"10.3389\/fphys.2018.00505","article-title":"BYD ameliorates oxidative stress-induced myocardial apoptosis in heart failure post-acute myocardial infarction via the P38 MAPK-CRYAB signaling pathway","volume":"9","author":"Zhang","year":"2018","journal-title":"Front. Physiol."},{"key":"10.1016\/j.jpba.2018.09.049_bib0050","doi-asserted-by":"crossref","first-page":"514","DOI":"10.3389\/fphar.2018.00514","article-title":"Integration of metabonomics and transcriptomics reveals the therapeutic effects and mechanisms of Baoyuan Decoction for myocardial ischemia","volume":"9","author":"Du","year":"2018","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.jpba.2018.09.049_bib0055","doi-asserted-by":"crossref","first-page":"5433","DOI":"10.1021\/ac5005103","article-title":"Quantitating metabolites in protein precipitated serum using NMR spectroscopy","volume":"86","author":"Nagana Gowda","year":"2014","journal-title":"Anal. Chem."},{"key":"10.1016\/j.jpba.2018.09.049_bib0060","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.trac.2014.06.007","article-title":"Metabolomics and traditional chinese medicine","volume":"61","author":"Hu","year":"2014","journal-title":"TrAC Trends Anal. Chem."},{"key":"10.1016\/j.jpba.2018.09.049_bib0065","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/s12291-013-0401-5","article-title":"\u03b2-Adrenoreceptor agonist isoproterenol alters oxidative status, inflammatory signaling, injury markers and apoptotic cell death in myocardium of rats","volume":"30","author":"Shukla","year":"2015","journal-title":"Indian J. Clin. Biochem."},{"key":"10.1016\/j.jpba.2018.09.049_bib0070","first-page":"3650","article-title":"Identification and function analysis of target group for cardioprotection of Baoyuan decoction","volume":"42","author":"Wan","year":"2017","journal-title":"China J. Chin. Mater. Med."},{"key":"10.1016\/j.jpba.2018.09.049_bib0075","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1016\/j.cjca.2017.03.009","article-title":"Complex energy metabolic changes in heart failure with preserved ejection fraction and heart Failure with reduced ejection fraction","volume":"33","author":"De Jong","year":"2017","journal-title":"Can. J. Cardiol."},{"key":"10.1016\/j.jpba.2018.09.049_bib0080","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1016\/j.etap.2015.03.014","article-title":"Astragalus polysaccharide attenuates isoproterenol-induced cardiac hypertrophy by regulating TNF-alpha\/PGC- 1alpha signaling mediated energy biosynthesis","volume":"39","author":"Luan","year":"2015","journal-title":"Environ. Toxicol. Pharmacol."},{"key":"10.1016\/j.jpba.2018.09.049_bib0085","article-title":"1H-NMR-based metabolic analysis of human serum reveals novel markers of myocardial energy expenditure in heart failure patients","volume":"9","author":"Du","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.jpba.2018.09.049_bib0090","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/s11897-016-0289-5","article-title":"Metabolic dysfunction in heart failure: diagnostic, prognostic, and pathophysiologic insights from metabolomic profiling","volume":"13","author":"Hunter","year":"2016","journal-title":"Curr. Heart Fail. Rep."},{"key":"10.1016\/j.jpba.2018.09.049_bib0095","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.jacbts.2016.11.009","article-title":"Metabolic origins of heart failure","volume":"2","author":"Wende","year":"2017","journal-title":"JACC Basic Transl. Sci."},{"key":"10.1016\/j.jpba.2018.09.049_bib0100","doi-asserted-by":"crossref","first-page":"2618","DOI":"10.1039\/c3mb70227h","article-title":"Metabolomic identification of diagnostic plasma biomarkers in humans with chronic heart failure","volume":"9","author":"Wang","year":"2013","journal-title":"Mol. Biosyst."},{"key":"10.1016\/j.jpba.2018.09.049_bib0105","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1161\/CIRCHEARTFAILURE.114.001469","article-title":"Energy metabolic reprogramming in the hypertrophied and early stage failing heart: a multisystems approach","volume":"7","author":"Lai","year":"2014","journal-title":"Circ. Heart Fail."},{"key":"10.1016\/j.jpba.2018.09.049_bib0110","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1074\/mcp.M700394-MCP200","article-title":"Urinary proteomic biomarkers in coronary artery disease","volume":"7","author":"Zimmerli","year":"2008","journal-title":"Mol. Cell Proteomics"},{"key":"10.1016\/j.jpba.2018.09.049_bib0115","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/j.cardfail.2015.04.005","article-title":"Cardiac resynchronization therapy induces adaptive metabolic transitions in the metabolomic profile of heart failure","volume":"21","author":"Nemutlu","year":"2015","journal-title":"J. Card. Fail."},{"key":"10.1016\/j.jpba.2018.09.049_bib0120","doi-asserted-by":"crossref","first-page":"2038","DOI":"10.1161\/CIRCULATIONAHA.115.020226","article-title":"Catabolic defect of branched-chain amino acids promotes heart failure","volume":"133","author":"Sun","year":"2016","journal-title":"Circulation"},{"key":"10.1016\/j.jpba.2018.09.049_bib0125","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/j.bbrc.2016.11.119","article-title":"Hypoxanthine causes endothelial dysfunction through oxidative stress-induced apoptosis","volume":"482","author":"Kim","year":"2017","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.jpba.2018.09.049_bib0130","first-page":"H2124","article-title":"Effects of methionine on endogenous antioxidants in the heart","volume":"277","author":"Seneviratne","year":"1999","journal-title":"Am. J. Physiol."},{"key":"10.1016\/j.jpba.2018.09.049_bib0135","doi-asserted-by":"crossref","first-page":"1860","DOI":"10.1093\/ajcn\/87.6.1860","article-title":"Consequences of low plasma histidine in chronic kidney disease patients: associations with inflammation, oxidative stress, and mortality","volume":"87","author":"Watanabe","year":"2008","journal-title":"Am. J. Clin. Nutr."},{"key":"10.1016\/j.jpba.2018.09.049_bib0140","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.cardfail.2014.11.006","article-title":"Intestinal microbiota-dependent phosphatidylcholine metabolites, diastolic dysfunction, and adverse clinical outcomes in chronic systolic heart failure","volume":"21","author":"Tang","year":"2015","journal-title":"J. Card. Fail."},{"key":"10.1016\/j.jpba.2018.09.049_bib0145","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1253\/circj.CJ-17-1184","article-title":"Metabolomic analysis in heart failure","volume":"82","author":"Ikegami","year":"2017","journal-title":"Circ. J."},{"key":"10.1016\/j.jpba.2018.09.049_bib0150","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1161\/CIRCULATIONAHA.116.024251","article-title":"The gut microbiome and its role in cardiovascular diseases","volume":"135","author":"Tang","year":"2017","journal-title":"Circulation"}],"container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0731708518308215?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0731708518308215?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,28]],"date-time":"2018-10-28T09:07:23Z","timestamp":1540717643000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0731708518308215"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1]]},"references-count":30,"alternative-id":["S0731708518308215"],"URL":"https:\/\/doi.org\/10.1016\/j.jpba.2018.09.049","relation":{},"ISSN":["0731-7085"],"issn-type":[{"value":"0731-7085","type":"print"}],"subject":[],"published":{"date-parts":[[2019,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"1H NMR-based dynamic metabolomics delineates the therapeutic effects of Baoyuan decoction on isoproterenol-induced cardiac hypertrophy","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmaceutical and Biomedical Analysis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpba.2018.09.049","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}